ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESR01

Genetic variation underlying innate lymphoid cell phenotypes across hosts

Active
Institution
Stanford University, CA
Principal investigator
Jennifer Kaoru Bando
Funding
$2.7M
Duration
2025–2029
Open portfolio

Moonbase score

Still being scored

Abstract

Project Summary Maintenance of gut epithelial homeostasis requires signals from a specialized set of RORγt+ innate lymphoid cells (ILCs) that reside in mucosa. RORγt+ ILCs directly regulate the gut barrier by secreting cytokines that activate epithelial host defense mechanisms and reinforce gut barrier integrity. Among the RORγt+ ILCs, there exists a set of phenotypically diverse cells characterized by distinct patterns of cytokine secretion, transcription factor expression, and physical distribution. Although a comprehensive understanding of the diversity of RORγt+ ILCs is required to mechanistically determine how to manipulate these cells, the full spectrum of ILCs remains to be examined. Our objective is to characterize the diversity of ILC subtypes, and define their development, function, and spatial regulation. Our long-term goal is to exploit mechanisms that control distinct innate lymphocyte subtypes to selectively manipulate these cells in vivo and restore mucosal homeostasis after intestinal dysregulation. We identified a specialized population of RORγt+T-bet+ ILCs that exhibited distinct patterns of expression of the chemokine receptor CCR6 compared to related ILCs. We also found that this chemokine receptor expression is associated with enhanced secretion of epithelial cell-active cytokines and was strongly regulated by genetic variation. We hypothesize that genetic variation in mouse strains results in distinct patterns of spatially distributed ILCs in tissue, which alter the capacity of RORγt+ ILCs to secrete mucosal cytokines. In Aim 1, we will investigate the developmental pathway of these newly described ILCs and identify genetic mechanisms regulating their expression of CCR6. In Aim 2, we will determine the impact of CCR6 on tissue localization of natural ILCs and their contribution to barrier immunity. These studies will provide insight into how diverse configurations of innate immune cells caused by genetic variation can shape underlying mucosal fitness.

LOADING MOONBASE SCORE

R01NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESDigestive System Host Defense, Microbial Interactions and Immune and Inflammatory Disease Study Section[DHMI]cytokinesvariationinnategenetic variationchemokinegut barriermucosalinnate lymphoid

Questions for Stanford University

Answered by the team behind this research.

Same institution, same topic, scored first.